TCG Crossover Management, LLC Q3 2025 Filing
Filed November 17, 2025
Portfolio Value
$2.0T
Holdings
40
Report Date
Q3 2025
Filing Type
13F-HR
All Holdings (40 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ABVXABIVAX SA AMERICAN DEPOSITARY SHARES | 7,111,596 | $603.8B | 29.70% | |
| 2 | CGONCG ONCOLOGY INC | 3,670,206 | $147.8B | 7.27% | |
| 3 | COGTCOGENT BIOSCIENCES INC | 6,798,162 | $97.6B | 4.80% | |
| 4 | AMLXAMYLYX PHARMACEUTICALS INC | 6,243,812 | $84.9B | 4.17% | |
| 5 | CNTACENTESSA PHARMACEUTICALS PLC | 3,136,480 | $76.1B | 3.74% | |
| 6 | TNGXTANGO THERAPEUTICS INC | 8,536,196 | $71.7B | 3.53% | |
| 7 | OCULOCULAR THERAPEUTIX INC | 6,117,232 | $71.5B | 3.52% | |
| 8 | DNTHDIANTHUS THERAPEUTICS INC | 1,676,624 | $66.0B | 3.25% | |
| 9 | TRMLTOURMALINE BIO INC | 1,311,783 | $62.7B | 3.09% | |
| 10 | DYNDYNE THERAPEUTICS INC | 4,615,144 | $58.4B | 2.87% | |
| 11 | AGIOAGIOS PHARMACEUTICALS INC | 1,430,041 | $57.4B | 2.82% | |
| 12 | EYPTEYEPOINT PHARMACEUTICALS INC | 3,572,335 | $50.9B | 2.50% | |
| 13 | FULCFULCRUM THERAPEUTICS INC | 5,250,000 | $48.3B | 2.38% | |
| 14 | YB4PSAVARA INC | 12,362,205 | $44.1B | 2.17% | |
| 15 | RAPTRAPT THERAPEUTICS INC | 1,636,275 | $42.2B | 2.08% | |
| 16 | TYRATYRA BIOSCIENCES INC | 2,898,103 | $40.5B | 1.99% | |
| 17 | UPBUPSTREAM BIO INC | 2,117,103 | $39.8B | 1.96% | |
| 18 | LQDALIQUIDIA TECHNOLOGIES INC | 1,710,084 | $38.9B | 1.91% | |
| 19 | IRONDISC MEDICINE INC | 465,257 | $30.7B | 1.51% | |
| 20 | GPCRSTRUCTURE THERAPEUTICS INC | 1,063,000 | $29.8B | 1.46% | |
| 21 | XNCRXENCOR INC | 2,452,138 | $28.8B | 1.41% | |
| 22 | LBRXLB PHARMACEUTICALS INC | 1,745,016 | $27.6B | 1.36% | |
| 23 | RVMDREVOLUTION MEDICINES INC | 436,473 | $20.4B | 1.00% | |
| 24 | CATBUSDASTRIA THERAPEUTICS INC | 2,761,861 | $20.1B | 0.99% | |
| 25 | KRROKORRO BIO INC | 416,301 | $19.9B | 0.98% | |
| 26 | KODKODIAK SCIENCES INC | 1,145,538 | $18.8B | 0.92% | |
| 27 | SYRESPYRE THERAPEUTICS INC | 1,100,582 | $18.4B | 0.91% | |
| 28 | SLNSILENCE THERAPEUTICS PLC | 3,033,560 | $15.7B | 0.77% | |
| 29 | URGNUROGEN PHARMA LTD | 717,347 | $14.3B | 0.70% | |
| 30 | ARVNARVINAS HOLDING CO LLC | 1,617,365 | $13.8B | 0.68% | |
| 31 | MNPRMONOPAR THERAPEUTICS INC | 153,000 | $12.5B | 0.61% | |
| 32 | MBXMBX BIOSCIENCES INC | 650,000 | $11.4B | 0.56% | |
| 33 | VTGNVISTAGEN THERAPEUTICS INC | 2,676,580 | $9.5B | 0.47% | |
| 34 | RLAYRELAY THERAPEUTICS INC | 1,810,351 | $9.5B | 0.46% | |
| 35 | AVU0ADVERUM BIOTECHNOLOGIES INC | 1,668,174 | $7.6B | 0.37% | |
| 36 | AVTXAVALO THERAPEUTICS INC | 483,000 | $6.1B | 0.30% | |
| 37 | ADCTADC THERAPEUTICS SA | 1,390,175 | $5.6B | 0.27% | |
| 38 | PEPGPEPGEN INC | 1,200,000 | $5.5B | 0.27% | |
| 39 | TRDAENTRADA THERAPEUTICS INC | 584,955 | $3.4B | 0.17% | |
| 40 | VTYXVENTYX BIOSCIENCES INC | 316,195 | $983.4M | 0.05% |